» Articles » PMID: 35918897

5-Fluorouracil Reduces the Fibrotic Scar Via Inhibiting Matrix Metalloproteinase 9 and Stabilizing Microtubules After Spinal Cord Injury

Overview
Specialties Neurology
Pharmacology
Date 2022 Aug 3
PMID 35918897
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Fibrotic scars composed of a dense extracellular matrix are the major obstacles for axonal regeneration. Previous studies have reported that antitumor drugs promote neurofunctional recovery.

Methods: We investigated the effects of 5-fluorouracil (5-FU), a classical antitumor drug with a high therapeutic index, on fibrotic scar formation, axonal regeneration, and functional recovery after spinal cord injury (SCI).

Results: 5-FU administration after hemisection SCI improved hind limb sensorimotor function of the ipsilateral hind paws. 5-FU application also significantly reduced the fibrotic scar formation labeled with aggrecan and fibronectin-positive components, Iba1 /CD11b macrophages/microglia, vimentin, chondroitin sulfate proteoglycan 4 (NG2/CSPG4), and platelet-derived growth factor receptor beta (PDGFRβ) pericytes. Moreover, 5-FU treatment promoted stromal cells apoptosis and inhibited fibroblast proliferation and migration by abrogating the polarity of these cells and reducing matrix metalloproteinase 9 expression and promoted axonal growth of spinal neurons via the neuron-specific protein doublecortin-like kinase 1 (DCLK1). Therefore, 5-FU administration impedes the formation of fibrotic scars and promotes axonal regeneration to further restore sensorimotor function after SCI.

Citing Articles

The Hidden Hand in White Matter: Pericytes and the Puzzle of Demyelination.

Raj S, Sarangi P, Goyal D, Kumar H ACS Pharmacol Transl Sci. 2024; 7(10):2912-2923.

PMID: 39421660 PMC: 11480894. DOI: 10.1021/acsptsci.4c00192.


The secretome of macrophages has a differential impact on spinal cord injury recovery according to the polarization protocol.

Lentilhas-Graca J, Santos D, Afonso J, Monteiro A, Pinho A, Mendes V Front Immunol. 2024; 15:1354479.

PMID: 38444856 PMC: 10912310. DOI: 10.3389/fimmu.2024.1354479.


Regenerative medicine strategies for chronic complete spinal cord injury.

Hashimoto S, Nagoshi N, Nakamura M, Okano H Neural Regen Res. 2023; 19(4):818-824.

PMID: 37843217 PMC: 10664101. DOI: 10.4103/1673-5374.382230.


5-Fluorouracil reduces the fibrotic scar via inhibiting matrix metalloproteinase 9 and stabilizing microtubules after spinal cord injury.

Xu Y, He X, Wang Y, Jian J, Peng X, Zhou L CNS Neurosci Ther. 2022; 28(12):2011-2023.

PMID: 35918897 PMC: 9627390. DOI: 10.1111/cns.13930.

References
1.
Jin Y, Park I, Hong I, Byun H, Choi J, Kim Y . Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin α(5)β(1)/α(v)β(3)-dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells. Cell Signal. 2010; 23(1):125-34. DOI: 10.1016/j.cellsig.2010.08.012. View

2.
Slotkin J, Pritchard C, Luque B, Ye J, Layer R, Lawrence M . Biodegradable scaffolds promote tissue remodeling and functional improvement in non-human primates with acute spinal cord injury. Biomaterials. 2017; 123:63-76. DOI: 10.1016/j.biomaterials.2017.01.024. View

3.
Li Y, He X, Kawaguchi R, Zhang Y, Wang Q, Monavarfeshani A . Microglia-organized scar-free spinal cord repair in neonatal mice. Nature. 2020; 587(7835):613-618. PMC: 7704837. DOI: 10.1038/s41586-020-2795-6. View

4.
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey M, Baker M . The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. J Cereb Blood Flow Metab. 2020; 40(9):1769-1777. PMC: 7430098. DOI: 10.1177/0271678X20943823. View

5.
Ren H, Han R, Liu X, Wang L, Koehler R, Wang J . Nrf2-BDNF-TrkB pathway contributes to cortical hemorrhage-induced depression, but not sex differences. J Cereb Blood Flow Metab. 2021; 41(12):3288-3301. PMC: 8669278. DOI: 10.1177/0271678X211029060. View